Gastroenteropancreatic neuroendocrine tumors: Role of surgery

被引:4
|
作者
Sauvanet, Alain [1 ]
机构
[1] Univ Paris Diderot, Hop Beaujon, AP HP, Dept HPB Surg,PMAD, 100 Blvd Gen Leclerc, F-92110 Clichy, France
关键词
Gastroenteropancreatic neuroendocrine tumors; Pancreatectomy; Pancreatic insufficiency; Observation; LYMPH-NODE INVOLVEMENT; ENDOCRINE TUMORS; SURGICAL-MANAGEMENT; PANCREATIC INSUFFICIENCY; SHORT-TERM; RESECTION; SURVIVAL; CM; LYMPHADENECTOMY; METAANALYSIS;
D O I
10.1016/j.ando.2019.04.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Natural history of gastroenteropancreatic (GEP) Neuroendocrine tumors (NETs) is better and better known so indications of surgery are presently selective. Surgical resection, but also endoscopic resection and observation, can be proposed for gastric NETs according to presentation, size and grade. For small bowel NETs, resection is frequently needed but should obtain the best compromise between radicality and postoperative functional disorders. Appendiceal NETs are frequently diagnosed by appendectomy for appendicitis, but some patients at high risk for lymph node metastasis and recurrence should be reoperated for radical resection. Rectal NETs are often diagnosed incidentally; the smallest (< 1 cm) can be resected endoscopically but the most aggressive need a oncological proctectomy. Pancreatic NETs represent a wide spectrum, ranging from fully benign tumors to very aggressive ones. lnsulinomas are mostly benign, responsible for incapacitating symptoms despite medical treatment, and should ideally be treated by parenchyma sparing resection, mainly enucleation. Conversely, symptoms of gastrinomas are efficiently treated medically but their resection needs an oncological approach. Nonfunctioning PNETs are more and more frequently and incidentally discovered. According to their size, presentation and patient's characteristics, they need a resection (oncological or parenchyma-sparing) or a close observation. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 50 条
  • [31] The Role of Chemotherapy in Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
    Strosberg, Jonathan
    Goldman, Jamie
    Costa, Frederico
    Pavel, Marianne
    NEUROENDOCRINE TUMORS: A MULTIDISCIPLINARY APPROACH, 2015, 44 : 239 - 247
  • [32] Update on the Management of Gastroenteropancreatic Neuroendocrine Tumors With Emphasis on the Role of Imaging
    Kim, Kyung Won
    Krajewski, Katherine M.
    Nishino, Mizuki
    Jagannathan, Jyothi P.
    Shinagare, Atul B.
    Tirumani, Sree Harsha
    Ramaiya, Nikhil H.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2013, 201 (04) : 811 - 824
  • [33] A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors
    Malczewska, Anna
    Kidd, Mark
    Matar, Somer
    Kos-Kudla, Beata
    Modlin, Irvin M.
    NEUROENDOCRINOLOGY, 2018, 107 (01) : 73 - 90
  • [34] The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors
    De Martino, Marco
    Pellecchia, Simona
    Esposito, Francesco
    Tosti, Nadia
    Quintavalle, Cristina
    Eppenberger-Castori, Serenella
    Carafa, Vincenza
    Righi, Alberto
    Chieffi, Paolo
    Fusco, Alfredo
    Terracciano, Luigi Maria
    Pallante, Pierlorenzo
    CELL CYCLE, 2022, 21 (12) : 1335 - 1346
  • [35] The Expanding Role of Somatostatin Analogs in Gastroenteropancreatic and Lung Neuroendocrine Tumors
    Mauro Cives
    Jonathan Strosberg
    Drugs, 2015, 75 : 847 - 858
  • [36] Mechanisms of Resistance in Gastroenteropancreatic Neuroendocrine Tumors
    Shi, Chanjuan
    Morse, Michael A.
    CANCERS, 2022, 14 (24)
  • [37] Gastroenteropancreatic neuroendocrine (carcinoid) tumors in children
    Johnson, Paul R. V.
    SEMINARS IN PEDIATRIC SURGERY, 2014, 23 (02) : 91 - 95
  • [38] Hereditary neuroendocrine tumors of the gastroenteropancreatic system
    Anlauf, Martin
    Garbrecht, Nele
    Bauersfeld, Juliane
    Schmitt, Anja
    Henopp, Tobias
    Komminoth, Paul
    Heitz, Philipp U.
    Perren, Aurel
    Kloeppel, Guenter
    VIRCHOWS ARCHIV, 2007, 451 : S29 - S38
  • [39] The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors
    Simon Schimmack
    Bernhard Svejda
    Benjamin Lawrence
    Mark Kidd
    Irvin M. Modlin
    Langenbeck's Archives of Surgery, 2011, 396 : 273 - 298
  • [40] Lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors
    Saif, Muhammad Wasif
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (03) : 443 - 456